Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
02/2011
02/24/2011US20110045522 Methods for diagnosing diabetes and determining effectiveness of treatments
02/24/2011US20110045521 Sample processing apparatus and sample processing method
02/24/2011US20110045520 Fatty acid markers for the diagnosis, prognosis and management of cardiovascular disease
02/24/2011US20110045519 Differentiated immortalised cell lines capable of producing albumin and blood coagulation factors, methods of preparing thereof from a leukaemia cell line and uses thereof
02/24/2011US20110045518 Ykl-40 as a general marker for non-specific disease
02/24/2011US20110045517 Toxic Material Detection Apparatus and Method
02/24/2011US20110045516 Kits Pertaining to Analyte Determination
02/24/2011US20110045515 Method to detect hemolytic streptococcus and optoelectrically determine results
02/24/2011US20110045514 Methods for detecting major adverse cardiovascular and cerebrovascular events
02/24/2011US20110045513 Protein electron mediator
02/24/2011US20110045512 Time-course measurement of enzymatic activity corrected for impacts of disturbances relating to the reaction of the enzyme with a substrate
02/24/2011US20110045497 Novel acidic glycan markers of human cells
02/24/2011US20110045496 Gal alpha 1-3gal-containing n-glycans in glycoprotein products derived from cho cells
02/24/2011US20110045492 Microfluidic system and a method of performing a test
02/24/2011US20110045491 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof
02/24/2011US20110045489 Polymerases for Incorporating Modified Nucleotides
02/24/2011US20110045488 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase
02/24/2011US20110045487 Methods of diagnosing myelodysplastic syndrome (mds) or leukemia using nucleic acids or fragments encoding flt3 kinase
02/24/2011US20110045486 Susceptibility Gene For Alzheimer's Disease
02/24/2011US20110045485 Analytical method and kit
02/24/2011US20110045484 Method of detecting target molecule by using aptamer
02/24/2011US20110045483 Diagnostic Screens for Alzheimer's Disease
02/24/2011US20110045482 Screening methods for identifying target antifungal genes and compounds by detecting cell surface glycoproteins
02/24/2011US20110045481 Methods and compositions for the assessment of drug response
02/24/2011US20110045480 Methods for predicting the efficacy of treatment
02/24/2011US20110045479 Method For High Resolution Melt Genotyping
02/24/2011US20110045478 Genetic Fingerprinting And Identification Method
02/24/2011US20110045477 Human skin explant culture system and use therefor
02/24/2011US20110045476 Inflammatory bowel disease prognostics
02/24/2011US20110045475 Upregulation of rack-1 in melanoma and its use as a marker
02/24/2011US20110045474 Copi molecules and uses thereof
02/24/2011US20110045473 Liver screening method
02/24/2011US20110045472 Monitoring enzymatic process
02/24/2011US20110045471 Methods for Assaying MC1R Variants and Mitochondrial Markers in Skin Samples
02/24/2011US20110045470 Pathogen detection in large-volume particulate samples
02/24/2011US20110045469 SNPs ASSOCIATED WITH FATTY ACID COMPOSITION OF BOVINE MEAT AND MILK
02/24/2011US20110045468 Polynucleotides for the identification and quantification of group a streptococcus nucleic acids
02/24/2011US20110045467 Peripheral neuropathy diagnosis
02/24/2011US20110045466 Field-effect transistor type biosensor and bio-signal amplification method thereof
02/24/2011US20110045465 Cancer Screening Method
02/24/2011US20110045464 Methods and compositions for identification of prostate cancer markers
02/24/2011US20110045463 Method for measuring dna methylation
02/24/2011US20110045462 Digital analysis of gene expression
02/24/2011US20110045461 Use of anti-microbial peptides as bacterial infection resistance markers in penaeoid shrimp
02/24/2011US20110045460 Mitochondrial complex I mutations in Parkinson's disease & aging
02/24/2011US20110045459 Molecular determinants of EGFR kinase inhibitor response in glioblastoma
02/24/2011US20110045458 Detection of Enterovirus
02/24/2011US20110045457 Assays for adsorbed influenza vaccines
02/24/2011US20110045456 Compositions for use in identification of adventitious contaminant viruses
02/24/2011US20110045053 Isolated population of luminal stem cells that give rise to prostate cancer and methods of using same
02/24/2011US20110045020 Nucleic acid comprising chimeric gene derived from hepatitis c virus
02/24/2011US20110045019 Porcine torque teno virus vaccines and diagnosis
02/24/2011US20110045018 Astrovirus species
02/24/2011US20110045010 Anti-lps factor from parietaria judaica and methods of use thereof
02/24/2011US20110045004 Method for in-vitro detecting pathogenic t helper cells and pharmaceutical compositions for treating autoimmune diseases
02/24/2011US20110044997 Methods
02/24/2011US20110044995 Anti-hiv monoclonal antibody
02/24/2011US20110044960 Medicament, dental material, and method of screening
02/24/2011US20110044959 Novel composition of stem cells for transplantation tolerance
02/24/2011US20110044956 Nell-1 enhanced bone mineralization
02/24/2011US20110044921 Substances and compositions for enhancing dna repair and methods of use
02/24/2011US20110044912 Diagnostic And Therapeutic Epitope, And Transgenic Plant
02/24/2011US20110044906 Methods for the Treatment, the Prognostic Assessment and the Staging of Non-Small Cell Lung Cancer
02/24/2011US20110044894 Immunoglobulin and/or Toll-Like Receptor Proteins Associated with Myelogenous Haematological Proliferative Disorders and Uses Thereof
02/24/2011US20110044527 Methods and Algorithms for Cell Enumeration in a Low-Cost Cytometer
02/24/2011US20110042344 Polymeric indicators for detecting the presence of metabolic byproducts from microorganisms
02/24/2011US20110042260 Compositions and methods for the treatment of tumor of hematopoietic origin
02/24/2011US20110042211 Biochemical test strip, measurement device, and biochemical test system
02/24/2011US20110041725 Anticoagulants as antifouling agents
02/24/2011DE10251709C5 Screening-Verfahren für Wirkstoffe zur Stimulierung der humanen beta-Defensine vom Typ 2 und/oder Typ 3 Screening method for agents to stimulate the human beta-defensins type 2 and / or type 3
02/24/2011DE102010004428B4 Untersuchungsverfahren/Screeningverfahren unter Einbeziehung lebender Zellen oder lebender Zellsysteme Investigation procedure / screening process involving living cells or living cellular systems
02/24/2011DE102009038017A1 Determination of microbial decomposition rates of first-order in fluid-saturated or fluid-partially saturated porous media of the soil- and groundwater areas, comprises flowing a water sample to be examined through successive reactors
02/24/2011CA2771786A1 In vivo screening assays
02/24/2011CA2771774A1 In vitro screening assays
02/24/2011CA2771699A1 Method of treating cancer
02/24/2011CA2771646A1 Dna ligands for aflatoxin and zearalenone
02/24/2011CA2771630A1 Therapeutic methods and compositions
02/24/2011CA2771597A1 Recombinant dna molecule encoding 5'utr capable of preventing inhibition of translation under environmental stresses
02/24/2011CA2771581A1 Detection of aad-1 event das-40278-9
02/24/2011CA2771538A1 Aad-1 event das-40278-9, related transgenic corn lines, and event-specific identification thereof
02/24/2011CA2771436A1 Pharmaceutical composition comprising anti-hb-egf antibody as active ingredient
02/24/2011CA2771303A1 Enhanced efficiency of induced pluripotent stem cell generation from human somatic cells
02/24/2011CA2771277A1 Cloning and expression of arnox protein transmembrane 9 superfamily (tm9sf), methods and utility
02/24/2011CA2768640A1 Apolipoprotein l-i variants and their use
02/23/2011EP2287619A1 Detection of foetal cells from maternal blood
02/23/2011EP2287618A2 Method for diagnosing neuro-degenerative disease
02/23/2011EP2287617A2 Method for diagnosing neuro-degenerative disease
02/23/2011EP2287614A1 Semiconductor nanocrystal probes for biological applications
02/23/2011EP2287608A2 Biomarkers for cardiovascular side-effects induced by cox-2 inhibitory compounds
02/23/2011EP2287341A1 Nucleic acid molecules containing recombination sites and methods of using the same
02/23/2011EP2287340A2 Method for diagnosis and treatment of a mental disease
02/23/2011EP2287339A1 Methods and kits to detect hereditary angioedema type III
02/23/2011EP2287338A1 Process for synthesizing nucleic acid
02/23/2011EP2287337A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours
02/23/2011EP2287336A1 Methods and processes for diagnosing Alzheimer's disease
02/23/2011EP2287335A1 Highly sensitive rapid isothermal method for the detection of methylation patterns
02/23/2011EP2287334A1 Method for documenting nucleic acids
02/23/2011EP2287333A1 Nucleic acids and methods for the detection of enterobacter sakazakii (cronobacter spp.)
02/23/2011EP2287332A1 Nucleic acids and methods for environmental monitoring
02/23/2011EP2287331A1 Method of processing excrement and container for processing excrement